| Description | CGP 19984 is a thiazolidinedione derivative that inhibits luteinizing hormone secretion and has anti-tumor effects. |
| molecular weight | 444.4 |
| Molecular formula | C13H18N4NaO6PS2 |
| CAS | 87958-64-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Shea WK, Black J, Ip MM. Short-term primary culture of rat prostate tumor epithelial cells on reconstituted basement membrane as a useful in vitro model to assess drug action on prostatic cancer: efficacy of the thiazolidinedione derivative CGP 19984. Prostate. 1989;15(2):157-70. Erratum in: Prostate 1990;16(2):185. PubMed PMID: 2798233. 2. Sylvester PW, Utz PJ, Ip MM. Effects of the thiazolidinedione derivative CGP 19984 on growth and endocrine function of the MtT-W10 transplantable mammosomatotropic pituitary tumor in female rats. Int J Cancer. 1988 Aug 15;42(2):289-94. PubMed PMID: 3403072. 3. Ip MM, Sylvester PW, Schenkel L. Antitumor efficacy in rats of CGP 19984, a thiazolidinedione derivative that inhibits luteinizing hormone secretion. Cancer Res. 1986 Apr;46(4 Pt 1):1735-40. PubMed PMID: 3948162. |